|
|
 |
|
Viewing report
|
|
|
|
Cardium Therapeutics, Inc. (CXM) - Product Pipeline Analysis
GlobalData, Aug 2011, Pages: 26
Cardium Therapeutics, Inc. (CXM) - Product Pipeline Analysis
Summary
Cardium Therapeutics, Inc. (Cardium) is a medical technology company that develops and commercializes biologic therapeutics and medical devices for cardiovascular and ischemic disease. The company holds a pipeline of products categorized into two operating units, namely, Cardium Biologics and Tissue Repair Company. Its lead product candidate, Generx, is a DNA-based growth factor therapeutic used by interventional cardiologists to stimulate the growth of collateral circulation in hearts of patients with ischemic conditions. The company also offers MedPodium healthy lifestyle product platform and web boutique. Cardium markets its products through third party collaborations throughout the world. The company owns two subsidiaries, namely, Post-Hypothermia Corporation and Tissue Repair Company, and is headquartered in California, the US.
This report is a source for data, analysis and actionable intelligence on the Cardium Therapeutics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Customers who bought this item also bought
Cardium Therapeutics, Inc. (CXM) - Financial and Strategic SWOT Analysis Review
Cardium Therapeutics, Inc. - Product Pipeline Review - Q4 2010
Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis
Advanced BioHealing, Inc. - Product Pipeline Analysis
Cardium Therapeutics, Inc. - Product Pipeline Review - Q4 2010
Healthpoint Biotherapeutics - Product Pipeline Analysis
AOI Medical, Inc. - Product Pipeline Analysis
ULURU Inc. (ULU) - Product Pipeline Analysis
PhotoThera, Inc. - Product Pipeline Analysis
GUIDED THERAPEUTICS, INC. (GTHP) - Product Pipeline Analysis
|
|
|
|
